Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2010
11/02/2010CA2394392C Process for labeling a ribonucleic acid, and labeled rna fragments which are obtained thereby
11/02/2010CA2392350C Hematological assay and reagent
11/02/2010CA2375974C Mammalian myeloid progenitor cell subsets
11/02/2010CA2352504C Plastidic phosphoglucomutase genes
11/02/2010CA2341520C Energy transfer dyes
11/02/2010CA2337422C Preventing airway mucus production by administration of egf-r antagonists
11/02/2010CA2302134C Composition and methods for monitoring the binding of a1/up1 to telomeric dna sequences and telomerase rna, and to measure the effect of this binding on telomere extension and protection
11/02/2010CA2265989C Methods for in vitro determination of erythropoietin bioactivity
11/02/2010CA2253246C Purified multimerase
11/02/2010CA2198702C Detection of hypermutable nucleic acid sequence in tissue
10/2010
10/28/2010WO2010124281A2 Selective detection of bordetella species
10/28/2010WO2010124277A2 Materials and methods for assessing and mapping microbes and microbial biofilms on wounds
10/28/2010WO2010124265A1 Polymorphisms in angiogenesis pathway genes associated with tumor recurrence in surgery treated cancer patients
10/28/2010WO2010124264A2 Genetic variants in angiogenesis pathway associated with clinical outcome
10/28/2010WO2010124257A2 Methods and kits for determining oxygen free radical (ofr) levels in animal and human tissues as a prognostic marker for cancer and other pathophysiologies
10/28/2010WO2010124240A2 Bin1 as a prognostic marker in cardiovascular disease
10/28/2010WO2010124239A2 Genetic polymorphisms associated with clinical outcomes of topoisomerase inhibitor therapy for cancer
10/28/2010WO2010124236A1 Polymorphism in k-ras 3' untranslated region associated with clinical outcomes of cancer treatments independent of k-ras mutation status
10/28/2010WO2010124222A2 Vegf and vegfr1 gene expression useful for cancer prognosis
10/28/2010WO2010124218A2 Genetic variants in il-6, p53, mmp-9 and cxcr predict clinical outcome in patients with cancer
10/28/2010WO2010124215A1 Gene expression levels of egfr, vegfr2, and ercc1 associated with clinical outcomes of chemotherapy
10/28/2010WO2010124157A1 Cellular assay employing detectable protein
10/28/2010WO2010124127A1 Integrated patient management and control system for medication delivery
10/28/2010WO2010124101A2 Genetic markers associated with endometriosis and use thereof
10/28/2010WO2010123982A2 Gene expression signatures associated with response to imatinib mesylate in gastrointestinal stromal tumors and use thereof for predicting patient response to therapy and identification of agents which have efficacy for the treatment of cancer
10/28/2010WO2010123949A1 Methods of detecting hpv strains using synergistic antibodies
10/28/2010WO2010123908A1 Biological specimen collection/transport compositions and methods
10/28/2010WO2010123827A1 Engineered demeter 5-methylcytosine dna glycosylase with improved yield, stability and solubility
10/28/2010WO2010123818A1 Breast cancer susceptibility gene gt198 and uses thereof
10/28/2010WO2010123626A1 Cd133 polymorphisms and expression predict clinical outcome in patients with cancer
10/28/2010WO2010123625A1 Cd133 polymorphisms predict clinical outcome in patients with cancer
10/28/2010WO2010123608A2 A spatial biomarker of disease and detection of spatial organization of cellular recptors
10/28/2010WO2010123519A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
10/28/2010WO2010123354A2 Method of diagnosing bladder cancer
10/28/2010WO2010123180A1 Pancreas tissue specific gene mmp1
10/28/2010WO2010123159A1 Marker for diagnosing lung cancer and colorectal cancer containing glutaredoxin 3 as active ingredient and kit for diagnosing lung cancer and colorectal cancer using the same
10/28/2010WO2010123136A1 Association of htra1 mutations and familial ischemic cerebral small-vessel disease
10/28/2010WO2010123124A1 Recurrence and prognosis factor for solid cancer, and use thereof for clinical purposes
10/28/2010WO2010123119A1 Therapeutic agent and screening method for inflammatory bowel disease
10/28/2010WO2010123096A1 Method for detecting intermolecular interaction
10/28/2010WO2010123085A1 Trapping compounds and method for identifying reactive metabolites
10/28/2010WO2010123069A1 Method for diagnosing autoimmune disease patient, in vitro diagnostic agent and therapeutic agent therefor
10/28/2010WO2010123065A1 Cancer antigen helper peptide
10/28/2010WO2010123058A1 Probe set for identification of nucleotide mutation, and method for identification of nucleotide mutation
10/28/2010WO2010123043A1 Method for evaluating cancer
10/28/2010WO2010122946A1 Periodontal disease markers
10/28/2010WO2010122673A1 Trapping compounds and method for identifying reactive metabolites
10/28/2010WO2010122243A1 Prognostic molecular signature of sarcomas, and uses thereof
10/28/2010WO2010122176A1 A method to identify glycosaminoglycan (gag) binding sites in proteins
10/28/2010WO2010122159A1 Compositions for use in security marking
10/28/2010WO2010122137A1 Hp1alpha as a prognostic marker in human cancer
10/28/2010WO2010121834A2 Irak kinase family as novel target and biomarker for alzheimer
10/28/2010WO2010121578A1 Method for in vitro diagnostics of invasive aspergillosis
10/28/2010WO2010121465A1 New serum-free medium for inducing pluripotent stem cells quickly with high efficiency and method using thereof
10/28/2010WO2010121380A1 Methods and compositions for lung cancer prognosis
10/28/2010WO2010121370A1 Prognostic gene expression signature for squamous cell carcinoma of the lung
10/28/2010WO2010121308A1 Detection of hepatitis c virus
10/28/2010WO2010121298A1 Detection of staphylococcus aureus
10/28/2010WO2010121294A1 Methods for obtaining fetal genetic material
10/28/2010WO2010090848A3 Apparatus and method to characterize blood and red blood cells via erythrocyte membrane fragility quantification
10/28/2010WO2010080559A3 Methods, compositions, and kits for detecting allelic variants
10/28/2010WO2010077366A3 Exponential isothermal self-sustained replication of an rna enzyme
10/28/2010WO2010077324A3 Methods, compositions, and kits for detecting allelic variants
10/28/2010WO2010075570A3 Methods, computer-accessible medium, and systems for score-driven whole-genome shotgun sequence assemble
10/28/2010WO2010065926A3 Methods for screening, predicting and monitoring prostate cancer
10/28/2010WO2010002883A3 Methods and devices for single-molecule whole genome analysis
10/28/2010US20100275323 for regulating expression of heterologous nucleotide sequences in a plant; regenerating a stably transformed plant from the transformed plant cell
10/28/2010US20100275320 Soybean sudden death syndrome resistant soybeans, soybean cyst nematode resistant soybeans and method of breeding and identifying resistant plants
10/28/2010US20100275286 Soybean Polymorphisms And Methods Of Genotyping
10/28/2010US20100275284 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
10/28/2010US20100275283 Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same
10/28/2010US20100275282 Methods and systems for identifying immunomodulatory substances
10/28/2010US20100275281 Multiple Inducible Gene Regulation System
10/28/2010US20100275280 Method for identifying, expanding and removing adult stem cells and cancer stem cells
10/28/2010US20100275279 Selecting animals for parentally imprinted traits
10/28/2010US20100275277 Infected nail of animal infected with fungus
10/28/2010US20100275275 HADHs as Modifiers of the p21 Pathway and Methods of Use
10/28/2010US20100273995 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin B and related compounds
10/28/2010US20100273943 Peptide conjugates and fluorescence detection methods for intracellular caspase assay
10/28/2010US20100273866 Diagnosis and treatment of cancer: i
10/28/2010US20100273865 Polypeptides involved in neuronal regeneration-associated gene expression
10/28/2010US20100273863 Modulation of Gene Expression Using Oligomers That Target Gene Regions Downstream of 3' Untranslated Regions
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273860 MODULATION OF APOLIPOPROTEIN (a) EXPRESSION
10/28/2010US20100273856 Screening of micro-rna cluster inhibitor pools
10/28/2010US20100273851 Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
10/28/2010US20100273738 Integrated patient management and control system for medication delivery
10/28/2010US20100273713 Diagnosis and Treatment of Congenital Heart Defects Using NELL1
10/28/2010US20100273711 Individualized cancer treatments
10/28/2010US20100273708 Adiponectin expression-inducing agents and uses thereof
10/28/2010US20100273707 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
10/28/2010US20100273680 Method and system for the analysis of high density cells samples
10/28/2010US20100273678 Method and kit to perform a pcr amplification and micro-array detection in the same medium and/or same chamber
10/28/2010US20100273675 Methods for detecting fetal abnormality
10/28/2010US20100273674 Method for the analysis of ovarian cancer disorders
10/28/2010US20100273668 Use of an endoplasmin fragment and derivatives thereof as biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
10/28/2010US20100273667 Cell culture well-plates having inverted colloidal crystal scaffolds
10/28/2010US20100273664 Method For The Determination Of Intra- And Intermolecular Interactions In Aqueous Solution
10/28/2010US20100273663 Methods and compositions related to arrhythmogenic right ventricular cardiomyopathy (ARVC)
10/28/2010US20100273661 Methods and Kits for Predicting Treatment Response in Type II Diabetes Mellitus Patients